secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVITA Medical, Inc. (RCEL)
CIK:        0001762303
Form:       8-K
Filed at:   2023-06-07T23:59:59+00:00
Accession:  0001193125-23-162334
Event type: other
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AVITA Medical stockholders approve 2.5M share increase in 2020 Omnibus Plan and new ESPP
--------------------------------------------------------------------------------

- Stockholders approved amendment to 2020 Omnibus Incentive Plan increasing shares by 2.5 million.
- Stockholders approved Employee Stock Purchase Plan authorizing up to 1 million shares.
- All seven director nominees elected; Grant Thornton LLP ratified as auditor for FY 2023.
- Advisory vote on named executive officer compensation approved: ~8.6M for, ~1.6M against.
- CEO James Corbett granted options to acquire 100,000 shares; non-employee directors receive RSUs and options.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1762303/000119312523162334/0001193125-23-162334-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1762303/000119312523162334/d488776d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-162334

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer